Clinical Trials in Austin

Showing 10641-10660 of 15,205 trials

Sequencing T-cells in Type I Diabetes Mellitus

NCT02040337

The purpose of this study is to investigate CD8 + T-cell receptor (TCR) repertoire differences between patients with type 1 diabetes mellitus and type 2 diabetes or healthy controls.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Seton Healthcare Family40 participantsStarted Apr 2014

Austin, Texas, United States

COMPLETEDPhase 3< 1 mile

A Study in Participants With Type 2 Diabetes Mellitus

NCT01468987

The purpose of this study is: * To compare blood glucose (blood sugar) control on LY2605541 with insulin glargine after 26 weeks of treatment. * To compare the rate of night time hypoglycemia (low blood glucose) on LY2605541 with insulin glargine during 26 weeks of treatment. * To compare the number of participants on LY2605541 reaching blood glucose targets without hypoglycemia episodes at night to those taking insulin glargine after 26 weeks of treatment. * To compare the rate of hypoglycemia over a 24-hour period on LY2605541 with insulin glargine during 26 weeks of treatment.

Diabetes Mellitus, Type 2

Eli Lilly and Company1,369 participantsStarted Dec 2011

Mobile, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +153 more locations

Sequencing T-cells in Type I Diabetes Mellitus

A Study in Participants With Type 2 Diabetes Mellitus

Find Trials by Condition in Austin

Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety

A Study in Patients With Type 2 Diabetes Mellitus

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses